Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | HTR2C | P28335 | 2/20 | 0.34 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.30 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
| ▸ | CA7 | P43166 | 1/20 | 0.30 |
| ▸ | CA9 | Q16790 | 1/20 | 0.30 |
| ▸ | MAP3K14 | Q99558 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9551788 | 0.68 | HTR2C (0.49) | CYP1A2CYP2A6ALDH1A1HTR2CTRPA1 | |
| SCHEMBL217130 | 0.66 | HTR2A (0.31) | — | |
| SCHEMBL9827233 | 0.60 | ALDH1A1 (0.34) | CYP1A2CYP2A6ALDH1A1HTR2CTRPA1 | |
| SCHEMBL12533329 | 0.57 | HTR2C (0.39) | CYP1A2CYP2A6ALDH1A1HTR2CTRPA1 | |
| SCHEMBL8086379 | 0.57 | CYP2A6 (0.41) | CYP1A2CYP2A6ALDH1A1TRPA1CA1 | |
| SCHEMBL16959393 | 0.57 | ALDH1A1 (0.46) | CYP1A2CYP2A6ALDH1A1HTR2CTRPA1 | |
| SCHEMBL29463284 | 0.56 | CYP1A2 (1.00) | CYP1A2CYP2A6ALDH1A1TRPA1CA1 | |
| SCHEMBL424167 | 0.56 | CYP1A2 (1.00) | CYP1A2CYP2A6ALDH1A1TRPA1CA1 | |
| SCHEMBL10474594 | 0.55 | — | — | |
| Bromide SCHEMBL11149886 | 0.55 | ALDH1A1 (0.88) | CYP1A2CYP2A6ALDH1A1HTR2CTRPA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118284281-A | Organic light emitting diode and organic light emitting device including the same | 乐金显示有限公司 | 2024-07-02 | — | — | CN | disclosed |
| CN-118265327-A | Organic light emitting diode and organic light emitting device including the same | 乐金显示有限公司 | 2024-06-28 | — | — | CN | disclosed |
| EP-4265624-A1 | COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME | Lg Chem, Ltd. (KR) | 2023-10-25 | — | — | EP | disclosed |
| US-20230320214-A1 | ORGANIC LIGHT-EMITTING DEVICE INCLUDING ORGANIC COMPOUND | LG CHEM, LTD. (KR) | 2023-10-05 | — | — | US | disclosed |
| EP-4194460-A1 | ORGANIC LIGHT-EMITTING DEVICE INCLUDING ORGANIC COMPOUND | Lg Chem, Ltd. (KR) | 2023-06-14 | — | — | EP | disclosed |
| CN-113875033-A | Organic light emitting device | 株式会社LG化学 | 2021-12-31 | — | — | CN | disclosed |
| CN-113646915-A | Organic light emitting device | 株式会社LG化学 | 2021-11-12 | — | — | CN | disclosed |
| CN-113396151-A | Polycyclic compound and organic light-emitting element comprising same | 株式会社LG化学 | 2021-09-14 | — | — | CN | disclosed |
| CN-113228335-A | Organic light emitting device | 株式会社LG化学 | 2021-08-06 | — | — | CN | disclosed |
| EP-2116523-B1 | REXINOID COMPOUND HAVING ALKOXY GROUP | UNIV OKAYAMA NAT UNIV CORP (JP) | 2015-05-06 | — | — | EP | disclosed |
| US-20030216586-A1 | Biaromatic compounds and pharmaceutical and cosmetic compositions comprising them | GALDERMA RESEARCH & DEVELOPMENT | 2003-11-20 | — | — | US | disclosed |
| US-6593493-B1 | 2-(Carboxy(unsaturated)alkyl)-1-(haloalkoxy)benzene derivatives; retinoid X receptors; cardiovascular, skin, eating and vision disorders; anticarcinogenic agents; non-insulin-dependent diabetes | LIGAND PHARMACEUTICALS, INC. | 2003-07-15 | — | — | US | disclosed |
| EP-1216221-A2 | RXR MODULATORS WITH IMPROVED PHARMACOLOGIC PROFILE | LIGAND PHARMACEUTICALS INCORPORATED (US) | 2002-06-26 | — | — | EP | disclosed |
| US-6346546-B1 | COMPOUNDS HAVING MARKED ACTIVITY IN FIELDS OF CELL DIFFERENTIATION AND PROLIFERATION; TREATING SKIN DISORDERS | GALDERMA RESEARCH & DEVELOPMENT (FR) | 2002-02-12 | — | — | US | disclosed |
| EP-0823903-B1 | HETEROCYCLIC DIARYL COMPOUNDS, PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING SAME, AND USES THEREOF | CT INTERNAT DE RECH S (FR) | 2001-07-18 | — | — | EP | disclosed |
| WO-2001019770-A2 | RXR MODULATORS WITH IMPROVED PHARMACOLOGIC PROFILE | LIGAND PHARMACEUTICALS INCORPORATED (US) | 2001-03-22 | — | — | WO | disclosed |
| US-6103762-A | A BIAROMATIC COMPOUNDS IN WHICH THE AROMATIC NUCLEI ARE CONNECTED BY A PROPYNYLENE OR ALLENYLENE DIVALENT RADICAL, USEFUL AS HUMAN OR VETERINARY MEDICINE OR USED IN COSMETICS OR KERATINIZATION DISORDERS | GALDERMA RESEARCH & DEVELOPMENT (FR) | 2000-08-15 | — | — | US | disclosed |
| US-5981776-A | FOR USE IN HUMAN OR VETERINARY MEDICINE (DERMATOLOGICAL, RHEUMATIC, RESPIRATORY, CARDIOVASCULAR AND OPHTHALMOLOGICAL COMPLAINTS IN PARTICULAR), OR ALTERNATIVELY IN COSMETIC COMPOSITIONS | CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA (FR) | 1999-11-09 | — | — | US | disclosed |
| EP-0823903-A1 | HETEROCYCLIC DIARYL COMPOUNDS, PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING SAME, AND USES THEREOF | CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA, ( CIRD GALDERMA) (FR) | 1998-02-18 | — | — | EP | disclosed |
| WO-1997029100-A1 | HETEROCYCLIC DIARYL COMPOUNDS, PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING SAME, AND USES THEREOF | CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA (C.I.R.D. GALDERMA) (FR) | 1997-08-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030216586-A1 | Biaromatic compounds and pharmaceutical and cosmetic compositions comprising them | AR, SRR, MC3R | CYP1A2 198/4885CYP2A6 53/4885ALDH1A1 680/4885 |
| US-20230320214-A1 | ORGANIC LIGHT-EMITTING DEVICE INCLUDING ORGANIC COMPOUND | CYP1A1, AOX1, CYP1B1 | CYP1A2 12/4885CYP2A6 116/4885ALDH1A1 8/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.